Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma.
Steendam CMJ, Peric R, van Walree NC, Youssef M, Schramel FMNH, Brocken P, van Putten JWG, van der Noort V, Veerman GDM, Koolen SLW, Groen HJM, Dingemans AC, Mathijssen RHJ, Smit EF, Aerts JGJV; NVALT Study Group. Steendam CMJ, et al. Among authors: van putten jwg. Lung Cancer. 2021 Oct;160:44-49. doi: 10.1016/j.lungcan.2021.08.002. Epub 2021 Aug 4. Lung Cancer. 2021. PMID: 34403911 Free article. Clinical Trial.
Iris metastasis in small-cell lung carcinoma.
Roenhorst AW, van den Bergh AC, van Putten JW, Smit EF. Roenhorst AW, et al. J Thorac Oncol. 2007 Dec;2(12):1128-9. doi: 10.1097/JTO.0b013e31815ba210. J Thorac Oncol. 2007. PMID: 18090588 Free article.
Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study.
Groen HJ, Sietsma H, Vincent A, Hochstenbag MM, van Putten JW, van den Berg A, Dalesio O, Biesma B, Smit HJ, Termeer A, Hiltermann TJ, van den Borne BE, Schramel FM. Groen HJ, et al. J Clin Oncol. 2011 Nov 10;29(32):4320-6. doi: 10.1200/JCO.2011.35.5214. Epub 2011 Oct 11. J Clin Oncol. 2011. PMID: 21990410 Clinical Trial.
Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer.
Cramer-van der Welle CM, Schramel FMNH, Peters BJM, van Putten JWG, Klungel OH, Groen HJM, van de Garde EMW; Santeon SCLC Study Group. Cramer-van der Welle CM, et al. Among authors: van putten jwg. Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):445-450. doi: 10.1002/pds.5179. Epub 2020 Dec 18. Pharmacoepidemiol Drug Saf. 2021. PMID: 33295644
45 results